Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KORU Medical Systems, Inc.KRMD · Entity 6517 | Director | October 01, 2026 | October 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KORU Medical Systems, Inc.
Report date October 01, 2026 · Filed October 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 103,633 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 5,119 · Balance 103,633 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 1, 2026 21:23 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,119 | $2.93 | $14,998.67 |
DisclosureSEC source: 0001161697-26-000223 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,633 Read SEC document |
| July 01, 2026 Filed Jul 1, 2026 21:19 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 3,571 | $4.20 | $14,998.20 |
DisclosureSEC source: 0001161697-26-000147 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,514 Read SEC document |
| April 01, 2026 Filed Apr 1, 2026 20:48 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 3,472 | $4.32 | $14,999.04 |
DisclosureSEC source: 0001161697-26-000082 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,943 Read SEC document |
| January 02, 2026 Filed Jan 2, 2026 23:51 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 2,581 | $5.81 | $14,995.61 |
DisclosureSEC source: 0001161697-26-000011 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,471 Read SEC document |
| October 02, 2025 Filed Oct 2, 2025 20:37 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 3,916 | $3.83 | $14,998.28 |
DisclosureSEC source: 0001161697-25-000336 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,890 Read SEC document |
| July 02, 2025 Filed Jul 2, 2025 20:53 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 4,189 | $33.58 | $140,666.62 |
DisclosureSEC source: 0001161697-25-000201 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,974 Read SEC document |
| April 02, 2025 Filed Apr 2, 2025 20:29 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,870 | $2.56 | $15,027.20 |
DisclosureSEC source: 0001161697-25-000133 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,785 Read SEC document |
| January 03, 2025 Filed Jan 3, 2025 21:29 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 3,937 | $3.81 | $14,999.97 |
DisclosureSEC source: 0001161697-25-000020 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,915 Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 20:05 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,454 | $2.75 | $14,998.50 |
DisclosureSEC source: 0001161697-24-000407 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,978 Read SEC document |
| July 11, 2024 Filed Jul 12, 2024 14:41 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,545 | $2.71 | $15,026.95 |
DisclosureSEC source: 0001161697-24-000308 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,524 Read SEC document |
| March 31, 2024 Filed Apr 1, 2024 20:11 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 6,329 | $2.37 | $14,999.73 |
DisclosureSEC source: 0001161697-24-000170 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,979 Read SEC document |
| December 31, 2023 Filed Jan 2, 2024 21:51 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 6,329 | $2.37 | $14,999.73 |
DisclosureSEC source: 0001161697-24-000010 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,650 Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 20:19 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,484 | $2.74 | $15,026.16 |
DisclosureSEC source: 0001161697-23-000518 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,321 Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:13 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 4,310 | $3.48 | $14,998.80 |
DisclosureSEC source: 0001161697-23-000392 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,837 Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:06 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 3,521 | $4.26 | $14,999.46 |
DisclosureSEC source: 0001161697-23-000215 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,330 Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 20:07 UTC Amendment | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 3,521 | $4.26 | $14,999.46 |
DisclosureSEC source: 0001161697-23-000235 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,527 Read SEC document |
| December 31, 2022 Filed Jan 3, 2023 21:50 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 4,273 | $3.51 | $14,998.23 |
DisclosureSEC source: 0001161697-23-000026 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,006 Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:53 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 6,681 | $2.25 | $15,032.25 |
DisclosureSEC source: 0001161697-22-000495 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,733 Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 22:08 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 6,002 | $2.50 | $15,005.00 |
DisclosureSEC source: 0001161697-22-000334 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,052 Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:12 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,221 | $2.87 | $14,984.27 |
DisclosureSEC source: 0001161697-22-000153 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,050 Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:18 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,000 | $3.00 | $15,000.00 |
DisclosureSEC source: 0001161697-22-000006 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,829 Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:07 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,263 | $2.85 | $14,999.55 |
DisclosureSEC source: 0001161697-21-000464 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,829 Read SEC document |
| June 30, 2021 Filed Jul 6, 2021 23:17 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 1,566 | $4.63 | $7,250.58 |
DisclosureSEC source: 0001161697-21-000330 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,566 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.